Target (CBDY) Shares Outstanding (Weighted Average) (2013 - 2023)

Target (CBDY) reported Shares Outstanding (Weighted Average) of $456.4 million for Q1 2023, down 26.03% year-over-year from $617.0 million in Q1 2022, and up 1048.35% quarter-over-quarter from $39.7 million in Q4 2022.

Target (CBDY) Shares Outstanding (Weighted Average) (2013 - 2023) Analysis & Trends

Target (CBDY) has 10 years of Shares Outstanding (Weighted Average) data on file, last reported at $456.4 million in Q1 2023.

  • Shares Outstanding (Weighted Average) for Q1 2023 came in at $456.4 million, down 26.03% year-over-year; the trailing twelve-month figure through Mar 2023 was $456.4 million (down 26.03% YoY), and the FY2022 annual result was $39.7 million, down 85.69% from the prior year.
  • Shares Outstanding (Weighted Average) advanced to $456.4 million in Q1 2023 per CBDY's latest filing, from $39.7 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $617.0 million in Q1 2022 and troughed at $7.2 million in Q2 2019.
  • A 4-year average of $323.5 million and a median of $421.9 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
  • On a YoY basis, Shares Outstanding (Weighted Average) climbed as much as 24.9% in 2022 and fell as far as 85.69% in 2022.
  • A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $7.2 million in 2019, then jumped by 3752.46% to $277.8 million in 2021, then tumbled by 85.69% to $39.7 million in 2022, then jumped by 1048.35% to $456.4 million in 2023.
  • Business Quant data shows CBDY's Shares Outstanding (Weighted Average) at $456.4 million in Q1 2023, $39.7 million in Q4 2022, and $473.1 million in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.16 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 166.20 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 64.74 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 228.36 Mn
10 Target - - 191,787.00 -

Historic Data

Download Data
DateValue
Mar 31, 2023 456.41 Mn
Dec 31, 2022 39.75 Mn
Sep 30, 2022 473.10 Mn
Jun 30, 2022 483.96 Mn
Mar 31, 2022 617.03 Mn
Dec 31, 2021 277.81 Mn
Sep 30, 2021 467.39 Mn
Jun 30, 2021 387.47 Mn
Jun 30, 2019 7.21 Mn
Mar 31, 2019 25.00 Mn
Sep 30, 2018 25.00 Mn
Jun 30, 2018 26.28 Mn
Mar 31, 2018 20.27 Mn
Dec 31, 2017 2.41 Mn
Sep 30, 2017 623,314.00
Jun 30, 2017 158,333.00
Mar 31, 2017 48,697.00
Dec 31, 2016 27,316.00
Sep 30, 2016 24,664.00
Jun 30, 2016 21.87 Mn